Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model

Bone

Volumn 48, Issue 6, 2011, Pages 1378-1387

  Zhang, Wei ^a,b   Rhodes, Steven D ^a   Zhao, Liming ^a,c   He, Yongzheng ^a   Zhang, Yingze ^b   Shen, Yong ^b   Yang, Dalong ^a,b   Wu, Xiaohua ^a   Li, Xiaohong ^a   Yang, Xianlin ^a   Park, Su Jung ^a   Chen, Shi ^a   Turner, Charles ^a,c   Yang, Feng Chun ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c Indiana University Purdue University Indianapolis   (United States)

Author keywords

Neurofibromatosis type 1; Osteoblast; Osteoclast; Osteopathy; Spinal deformity

Indexed keywords

COLLAGEN TYPE 2; CRE RECOMBINASE; NEUROFIBROMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE MASS; BONE STRESS; CELL COUNT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DISEASE MODEL; DUAL ENERGY X RAY ABSORPTIOMETRY; HISTOPATHOLOGY; LUMBAR VERTEBRA; MOLECULAR MECHANICS; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PATHOGENESIS; QUANTITATIVE ANALYSIS; SPINE MALFORMATION; TRABECULAR BONE; VERTEBRAL CANAL; WEIGHT BEARING;

ABSORPTIOMETRY, PHOTON; ANIMALS; BIOMECHANICS; DISEASE MODELS, ANIMAL; GENES, NEUROFIBROMATOSIS 1; MICE; MICE, KNOCKOUT; NEUROFIBROMATOSIS 1; SPINE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79955894043     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.03.760     Document Type: Article

References (62)

1. Wallace M.R., Marchuk D.A., Andersen L.B., Letcher R., Odeh H.M., Saulino A.M., et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990, 249:181-186.
2. Atit R.P., Mitchell K., Nguyen L., Warshawsky D., Ratner N. The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice. J Invest Dermatol 2000, 114:1093-1100.
3. Atit R.P., Crowe M.J., Greenhalgh D.G., Wenstrup R.J., Ratner N. The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol 1999, 112:835-842.
4. Bajenaru M.L., Hernandez M.R., Perry A., Zhu Y., Parada L.F., Garbow J.R., et al. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res 2003, 63:8573-8577.
5. Cichowski K., Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001, 104:593-604.
6. Cawthon R.M., Weiss R., Xu G.F., Viskochil D., Culver M., Stevens J., et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 1990, 62:193-201.
7. Zhu Y., Ghosh P., Charnay P., Burns D.K., Parada L.F. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 2002, 296:920-922.
8. Ajuebor M.N., Hogaboam C.M., Kunkel S.L., Proudfoot A.E., Wallace J.L. The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J Immunol 2001, 166:552-558.
9. Rutkowski J.L., Wu K., Gutmann D.H., Boyer P.J., Legius E. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet 2000, 9:1059-1066.
10. Ingram D.A., Yang F.C., Travers J.B., Wenning M.J., Hiatt K., New S., et al. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 2000, 191:181-188.
11. Yang F.C., Ingram D.A., Chen S., Hingtgen C.M., Ratner N., Monk K.R., et al. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells. J Clin Invest 2003, 112:1851-1861.
12. Johannessen C.M., Reczek E.E., James M.F., Brems H., Legius E., Cichowski K. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A 2005, 102:8573-8578.
13. Gould E. The bone changes occuring in Von Recklinghausen's disease. Q J Med 1918, 11:221-228.
14. Weiss R. (A) Von Recklinghausen's disease in the Negro; (B) curvature of the spine in von Recklinghausen's disease. Arch Dermatol Syphilol 1921, 3:144-151.
15. Kuorilehto T., Kinnunen P., Nissinen M., Alanne M., Leskela H.V., Lehenkari P., et al. Vasculopathy in two cases of NF1-related congenital pseudarthrosis. Pathol Res Pract 2006, 202:687-690.
16. Kuorilehto T., Nissinen M., Koivunen J., Benson M.D., Peltonen J. NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos. J Bone Miner Res 2004, 19:983-989.
17. Kuorilehto T., Poyhonen M., Bloigu R., Heikkinen J., Vaananen K., Peltonen J. Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int 2005, 16:928-936.
18. Lammert M., Kappler M., Mautner V.F., Lammert K., Storkel S., Friedman J.M., et al. Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int 2005, 16:1161-1166.
19. Jacques C., Dietemann J.L. Imaging features of neurofibromatosis type 1. J Neuroradiol 2005, 32:180-197.
20. Illes T., Halmai V., de Jonge T., Dubousset J. Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos Int 2001, 12:823-827.
21. Heuze Y., Piot B., Mercier J. Difficult surgical management of facial neurofibromatosis type I or von Recklinghausen disease in children. Rev Stomatol Chir Maxillofac 2002, 103:105-113.
22. Stevenson D.A., Moyer-Mileur L.J., Murray M., Slater H., Sheng X., Carey J.C., et al. Bone mineral density in children and adolescents with neurofibromatosis type 1. J Pediatr 2007, 150:83-88.
23. Stevenson D.A., Zhou H., Ashrafi S., Messiaen L.M., Carey J.C., D'Astous J.L., et al. Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet 2006, 79:143-148.
24. Riccardi V.M. Von Recklinghausen neurofibromatosis. N Engl J Med 1981, 305:1617-1627.
25. Crawford A.H., Bagamery N. Osseous manifestations of neurofibromatosis in childhood. J Pediatr Orthop 1986, 6:72-88.
26. Crawford A.H. Pitfalls of spinal deformities associated with neurofibromatosis in children. Clin Orthop Relat Res 1989, 29-42.
27. Overweg-Plandsoen W.C., Weersink R.G., Sillevis Smitt J.H., Fleury P., van Asperen C.J. Neurofibromatosis type 1: a survey of 195 patients. Ned Tijdschr Geneeskd 1997, 141:624-629.
28. Garfin S.R. Cervical Spine Research Society Presidential Address: a 25-year correlation with history. Spine (Phila Pa 1976) 1997, 22:2589-2597.
29. Tsirikos A.I., Ramachandran M., Lee J., Saifuddin A. Assessment of vertebral scalloping in neurofibromatosis type 1 with plain radiography and MRI. Clin Radiol 2004, 59:1009-1017.
30. Alwan S., Armstrong L., Joe H., Birch P.H., Szudek J., Friedman J.M. Associations of osseous abnormalities in Neurofibromatosis 1. Am J Med Genet A 2007, 143A:1326-1333.
31. Jacks T., Shih T.S., Schmitt E.M., Bronson R.T., Bernards A., Weinberg R.A. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 1994, 7:353-361.
32. Elefteriou F., Benson M.D., Sowa H., Starbuck M., Liu X., Ron D., et al. ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab 2006, 4:441-451.
33. Kolanczyk M., Kossler N., Kuhnisch J., Lavitas L., Stricker S., Wilkening U., et al. Multiple roles for neurofibromin in skeletal development and growth. Hum Mol Genet 2007, 16:874-886.
34. Kuorilehto T., Ekholm E., Nissinen M., Hietaniemi K., Hiltunen A., Paavolainen P., et al. NF1 gene expression in mouse fracture healing and in experimental rat pseudarthrosis. J Histochem Cytochem 2006, 54:363-370.
35. Schindeler A., Ramachandran M., Godfrey C., Morse A., McDonald M., Mikulec K., et al. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice. J Orthop Res 2008, 26:65-74.
36. Dacquin R., Starbuck M., Schinke T., Karsenty G. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev Dyn 2002, 224:245-251.
37. Liu F., Woitge H.W., Braut A., Kronenberg M.S., Lichtler A.C., Mina M., et al. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. Int J Dev Biol 2004, 48:645-653.
38. Kwon C.H., Zhao D., Chen J., Alcantara S., Li Y., Burns D.K., et al. Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res 2008, 68:3286-3294.
39. Yu X., Chen S., Potter O.L., Murthy S.M., Li J., Pulcini J.M., et al. Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Bone 2005, 36:793-802.
40. Koller D.L., Liu L., Alam I., Sun Q., Econs M.J., Foroud T., et al. Epistasis between QTLs for bone density variation in Copenhagen x dark agouti F2 rats. Mamm Genome 2009, 20:180-186.
41. Milne M., Kang M.I., Quail J.M., Baran D.T. Thyroid hormone excess increases insulin-like growth factor I transcripts in bone marrow cell cultures: divergent effects on vertebral and femoral cell cultures. Endocrinology 1998, 139:2527-2534.
42. Ishida Y., Heersche J.N. Progesterone- and dexamethasone-dependent osteoprogenitors in bone cell populations derived from rat vertebrae are different and distinct. Endocrinology 1999, 140:3210-3218.
43. Wu X., Estwick S.A., Chen S., Yu M., Ming W., Nebesio T.D., et al. Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells. Hum Mol Genet 2006, 15:2837-2845.
44. Ge Y., Chen D., Xie L., Zhang R. Enhancing effect of daidzein on the differentiation and mineralization in mouse osteoblast-like MC3T3-E1 cells. Yakugaku Zasshi 2006, 126:651-656.
45. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
46. Yang F.C., Chen S., Robling A.G., Yu X., Nebesio T.D., Yan J., et al. Hyperactivation of p21 and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions. J Clin Invest 2006, 116:2880-2891.
47. Yilmaz K., Ozmen M., Bora Goksan S., Eskiyurt N. Bone mineral density in children with neurofibromatosis 1. Acta Paediatr 2007, 96:1220-1222.
48. Crawford A.H., Herrera-Soto J. Scoliosis associated with neurofibromatosis. Orthop Clin North Am 2007, 38:553-562. vii.
49. Crawford A.H., Schorry E.K. Neurofibromatosis update. J Pediatr Orthop 2006, 26:413-423.
50. Kwok E.S., Sawatzky B., Birch P., Friedman J.M., Tredwell S.J. Vertebral scalloping in neurofibromatosis type 1: a quantitative approach. Can J Surg 2002, 45:181-184.
51. Vitale M.G., Guha A., Skaggs D.L. Orthopaedic manifestations of neurofibromatosis in children: an update. Clin Orthop Relat Res 2002, 107-118.
52. Funasaki H., Winter R.B., Lonstein J.B., Denis F. Pathophysiology of spinal deformities in neurofibromatosis. An analysis of seventy-one patients who had curves associated with dystrophic changes. J Bone Joint Surg Am 1994, 76:692-700.
53. Yang F.C., Ingram D.A., Chen S., Zhu Y., Yuan J., Li X., et al. Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow. Cell 2008, 135:437-448.
54. Daginakatte G.C., Gianino S.M., Zhao N.W., Parsadanian A.S., Gutmann D.H. Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation. Cancer Res 2008, 68:10358-10366.
55. Daginakatte G.C., Gutmann D.H. Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. Hum Mol Genet 2007, 16:1098-1112.
56. Yan J., Chen S., Zhang Y., Li X., Li Y., Wu X., et al. Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1. Hum Mol Genet 2008, 17:936-948.
57. Li H., Liu Y., Zhang Q., Jing Y., Chen S., Song Z., et al. Ras dependent paracrine secretion of osteopontin by Nf1+/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine model. Pediatr Res 2009.
58. Goff C.W., Landmesser W. Bipedal rats and mice; laboratory animals for orthopaedic research. J Bone Joint Surg Am 1957, 39-A:616-622.
59. Casselman E.S., Mandell G.A. Vertebral scalloping in neurofibromatosis. Radiology 1979, 131:89-94.
60. Alwan S., Tredwell S.J., Friedman J.M. Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)?. Clin Genet 2005, 67:378-390.
61. Abdel-Wanis M.E., Kawahara N. The role of neurofibromin and melatonin in pathogenesis of pseudarthrosis after spinal fusion for neurofibromatous scoliosis. Med Hypotheses 2002, 58:395-398.
62. Ramachandran M., Tsirikos A.I., Lee J., Saifuddin A. Whole-spine magnetic resonance imaging in patients with neurofibromatosis type 1 and spinal deformity. J Spinal Disord Tech 2004, 17:483-491.